Inventor · disambiguated record
Dean R. Dragoli
Also filed as: DRAGOLI DEAN · DRAGOLI DEAN R
33 granted patents·13 pending applications·112 citations·filing 2006–2025
96Inventor score
Top patents by PatentIndex Score
46 records- 0198US9834545B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2016·Granted Dec 5, 2017·26 cites·33 claims
- 0297US9809581B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2016·Granted Nov 7, 2017·23 cites·29 claims
- 0394US10370363B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2017·Granted Aug 6, 2019·6 cites·13 claims
- 0494US10336736B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2017·Granted Jul 2, 2019·6 cites·24 claims
- 0591US10988464B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2019·Granted Apr 27, 2021·3 cites·16 claims
- 0690US11040960B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Jun 22, 2021·3 cites·14 claims
- 0789US10759789B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2019·Granted Sep 1, 2020·2 cites·27 claims
- 0889US10421748B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2018·Granted Sep 24, 2019·3 cites·43 claims
- 0987US11242337B2Compounds useful for treating gastrointestinal tract disordersARDELYX INC·Filed 2018·Granted Feb 8, 2022·3 cites·20 claims
- 1087US10376481B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2017·Granted Aug 13, 2019·3 cites·32 claims
- 1187US9750722B2Diazole amidesCHEMOCENTRYX INC·Filed 2015·Granted Sep 5, 2017·5 cites·23 claims
- 1286US11434230B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2020·Granted Sep 6, 2022·1 cites·14 claims
- 1386US10968246B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2019·Granted Apr 6, 2021·2 cites·27 claims
- 1485US10744118B2Diazole lactamsCHEMOCENTRYX INC·Filed 2016·Granted Aug 18, 2020·2 cites·15 claims
- 1585US9169248B2Diazole amidesCHEMOCENTRYX INC·Filed 2013·Granted Oct 27, 2015·6 cites·22 claims
- 1683US12281103B2Compounds useful for treating gastrointestinal tract disordersARDELYX INC·Filed 2023·Granted Apr 22, 2025·0 cites·17 claims
- 1783US12139475B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2022·Granted Nov 12, 2024·0 cites·4 claims
- 1883US9328116B2Diazole lactamsCHEMOCENTRYX INC·Filed 2013·Granted May 3, 2016·4 cites·4 claims
- 1981US9340509B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2014·Granted May 17, 2016·4 cites·17 claims
- 2080US10392413B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2016·Granted Aug 27, 2019·3 cites·39 claims
- 2180US9795599B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2016·Granted Oct 24, 2017·2 cites·24 claims
- 2279US2025067907A1Compounds and methods for treating hyperkalemiaARDELYX INC·Filed 2024·Application pending·0 cites
- 2378US10117865B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2017·Granted Nov 6, 2018·1 cites·6 claims
- 2477US8853202B2Modulators of CXCR7CHEN XI·Filed 2010·Granted Oct 7, 2014·4 cites·10 claims
- 2575US2023273354A1Glycyrrhetinic acid derivatives for treating hyperkalemiaARDELYX INC·Filed 2023·Application pending·0 cites
- 2675US2025263401A1Compounds useful for treating gastrointestinal tract disordersARDELYX INC·Filed 2025·Application pending·0 cites
- 2774US11945805B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2021·Granted Apr 2, 2024·0 cites·9 claims
- 2873US11820759B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2021·Granted Nov 21, 2023·0 cites·8 claims
- 2973US10786494B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2018·Granted Sep 29, 2020·0 cites·5 claims
- 3073US2022306610A1Compounds useful for treating gastrointestinal tract disordersARDELYX INC·Filed 2021·Application pending·0 cites
- 3172US2024209019A1Compounds and methods for treating hyperkalemiaARDELYX INC·Filed 2023·Application pending·0 cites
- 3269US2025388615A9Substituted 4-phenyl pyridine compounds as non-systemic tgr5 agonistsARDELYX INC·Filed 2024·Application pending·0 cites
- 3368US11759454B2Diazole lactamsCHEMOCENTRYX INC·Filed 2020·Granted Sep 19, 2023·0 cites·16 claims
- 3463US2019374533A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2018·Application pending·0 cites
- 3562US2025188093A1Tyk2 inhibitors and uses thereofALUMIS INC·Filed 2023·Application pending·0 cites
- 3662US2025213571A1Tyk2 inhibitors and uses thereofALUMIS INC·Filed 2023·Application pending·0 cites
- 3762US2017204087A12-oxindole compoundsCHEMOCENTRYX INC·Filed 2017·Application pending·0 cites
- 3859US11858959B2Glycyrrhetinic acid derivatives for use in treating hyperkalemiaARDELYX INC·Filed 2020·Granted Jan 2, 2024·0 cites·22 claims
- 3959US11768319B2Glycyrrhetinic acid derivatives for treating hyperkalemiaARDELYX INC·Filed 2018·Granted Sep 26, 2023·0 cites·18 claims
- 4059US10342781B2Diazole amidesCHEMOCENTRYX INC·Filed 2017·Granted Jul 9, 2019·0 cites·8 claims
- 4157US9181241B2Antagonists of chemokine receptorsCHEMOCENTRYX INC·Filed 2013·Granted Nov 10, 2015·0 cites·19 claims
- 4256US12084472B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2021·Granted Sep 10, 2024·0 cites·54 claims
- 4356US2018369213A1Antagonists of chemokine receptorsCHEMOCENTRYX INC·Filed 2018·Application pending·0 cites
- 4449US2016193191A1Antagonists of chemokine receptorsCHEMOCENTRYX INC·Filed 2015·Application pending·0 cites
- 4549US2007112015A1Substituted dihydropyridines and methods of useCHEMOCENTRYX INC·Filed 2006·Application pending·0 cites
- 4643US11147884B2Inhibitors of NHE-mediated antiportARDELYX INC·Filed 2018·Granted Oct 19, 2021·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Dean R. Dragoli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →